Novanta Is Maintained at Neutral by Baird
Novanta Analyst Ratings
Baird Maintains Novanta(NOVT.US) With Hold Rating, Cuts Target Price to $169
Baird Initiates Novanta(NOVT.US) With Hold Rating, Announces Target Price $175
Novanta Analyst Ratings
Baird Maintains Neutral on Novanta, Raises Price Target to $175
Analysts Offer Insights on Technology Companies: PROS Holdings (PRO), Novanta (NOVT) and Corsair Gaming (CRSR)
Analysts Offer Insights on Technology Companies: Novanta (NOVT), Bentley Systems (BSY) and Wallbox (WBX)
Analysts Have Conflicting Sentiments on These Industrial Goods Companies: Novanta (NOVT), Tecnoglass (TGLS) and United Parcel (UPS)
Baird Adjusts Price Target on Novanta to $161 From $150, Maintains Neutral Rating
Analysts Conflicted on These Technology Names: Novanta (NOVT) and Health Catalyst (HCAT)
Berenberg Bank Adjusts Novanta Price Target to $130 From $132, Maintains Hold Rating
Analysts' Opinions Are Mixed on These Technology Stocks: Novanta (NOVT), Health Catalyst (HCAT) and Matterport (MTTR)
Robert W. Baird Sticks to Their Hold Rating for Novanta (NOVT)